NIH toxicology contract renewed for MRIGlobal despite tightening budget
The tightening federal budget is increasing competition between research institutes and academia when it comes to preclinical toxicology testing, according to MRIGlobal.
Archives for August 5, 2014
Injectables outsourcing growing despite pharma M&A, says AMRI
Big Pharma is still reliant on CMOs despite talk of returning in-house, says AMRI, which has launched into the top ten manufacturers in the US injectables sector following its recent acquisition.
Kentucky firm ramps production of plant-based antibodies used to treat two Ebola patients
Two Americans stricken with the Ebola virus in Liberia were flown back to the US following treatment with an unapproved treatment manufactured from tobacco plants in Kentucky. Manufacturing of the treatment is expected to ramp up as the patients improve.
Anti-addiction formulation rules on the way says drug abuse non-profit
The Center for Lawful Access and Abuse Deterrence (CLAAD) is working with the US Food and Drug Administration (FDA) on legislation for abuse-deterrent technology in opioids, its directors tell in-PharmaTechnologist.com.
Oncologist: Delivery is key for improving pancreatic cancer treatment
Pancreatic cancer is notoriously difficult to treat. One problem is drug delivery, because pancreatic cells can cluster in a nest of scar-like tissue.
Actavis welcomes AZ in boosting its LAMA/LABA
Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist (LAMA/LABA) fixed dose combination respiratory drug following the latter’s acquisition of Almirall.
Impax hit with another US FDA Form 483
A week after receiving an FDA Form 483 for its Taiwan site, Impax Laboratories received another Form 483 for its Hayward, California site.
Premier acquires clinical surveillance software provider for $117m
Healthcare company Premier has purchased Hospira subsidiary TheraDoc, a provider of electronic clinical surveillance, for $117m (€87.5m).